Meliodays and Celanese Partner for Meliodays' Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain

• click to rate

  Posted by Two Blokes Jul 29 - Filed in Stock - 4 views
  
  MUNICH, July 29, 2025 (GLOBE NEWSWIRE) -- Meliodays Medical and Celanese Corporation (NYSE: CE) have signed an agreement related to Meliodays' pre-clinical development of MelioOne\u00ae, the first hormone-free non-contraceptive intrauterine device (IUD) designed to deliver localized relief for menstrual pain. MelioOne\u00ae combines the proven VitalDose\u00ae Drug Delivery Platform from Celanese with Meliodays' innovative IUD design and non-hormonal active pharmaceutical ingredient (API).